Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN) View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-03

AUTHORS

Grace Kong, Simona Grozinsky-Glasberg, Michael S. Hofman, Tim Akhurst, Amichay Meirovitz, Ofra Maimon, Yodphat Krausz, Jeremy Godefroy, Michael Michael, David J. Gross, Rodney J. Hicks

ABSTRACT

PURPOSE: Rectal neuroendocrine neoplasia (NEN) is more common than other NEN origins, but is less commonly metastatic. However, when present, distant disease carries a particularly poor prognosis. Evidence guiding optimal treatment of such patients is lacking. We assessed PRRT outcomes in patients with somatostatin receptor (SSTR) positive metastatic rectal NEN from two referral centres. METHODS: Patients treated with PRRT were retrospectively reviewed. Morphologic (RECIST 1.1), SSTR imaging responses and toxicity were assessed 3 months post-PRRT. Kaplan-Meier estimate was used to determine progression-free survival (PFS) and overall survival (OS) from start of PRRT. RESULTS: Twenty-seven consecutive patients (M = 20, age 31-81 years) were reviewed. The majority (70%) had ENETs grade 2 disease (19 patients), three had Grade 3, one Grade 1, and four not documented. Overall, 63% (10/16 patients with available FDG PET/CT) had FDG avid disease. Twenty-six patients were treated for disease progression. Most had 177Lu-DOTA-octreotate with median cumulative activity of 30 GBq, median four cycles. 14 patients had radiosensitising chemotherapy (5FU or capecitabine). At 3 months post-PRRT, CT disease control rate (DCR) was 96%: partial response was observed in 70% (19/27) and stable disease in 26%. All but one had partial SSTR imaging response. The median PFS was 29 months. Ten patients died, with median overall survival 81 months with a median follow-up of 67 months. Seventeen patients had further treatments after initial PRRT (10 had further cycles of PRRT). Three patients had grade 3 lymphopenia, without significant renal toxicity, MDS or leukaemia. CONCLUSION: Our results indicate high efficacy and morphologic responses with minimal toxicity and very encouraging survival from PRRT in patients with metastatic rectal NEN despite the adverse prognostic features of this cohort. Further prospective PRRT trials are warranted in this subgroup. More... »

PAGES

1-10

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-018-4196-8

DOI

http://dx.doi.org/10.1007/s00259-018-4196-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107740065

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30343432


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Centre for Cancer Imaging, Peter MacCallum Cancer Centre, 305 Grattan Street, 3000, Melbourne, VIC, Australia", 
            "Neuroendocrine Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kong", 
        "givenName": "Grace", 
        "id": "sg:person.01122451566.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122451566.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hadassah Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.17788.31", 
          "name": [
            "Neuroendocrine Tumour Unit, Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grozinsky-Glasberg", 
        "givenName": "Simona", 
        "id": "sg:person.01126121154.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126121154.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Centre for Cancer Imaging, Peter MacCallum Cancer Centre, 305 Grattan Street, 3000, Melbourne, VIC, Australia", 
            "Neuroendocrine Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hofman", 
        "givenName": "Michael S.", 
        "id": "sg:person.01012460764.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012460764.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Centre for Cancer Imaging, Peter MacCallum Cancer Centre, 305 Grattan Street, 3000, Melbourne, VIC, Australia", 
            "Neuroendocrine Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Akhurst", 
        "givenName": "Tim", 
        "id": "sg:person.014667211005.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014667211005.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hadassah Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.17788.31", 
          "name": [
            "Oncology Department and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meirovitz", 
        "givenName": "Amichay", 
        "id": "sg:person.016475560707.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016475560707.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hadassah Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.17788.31", 
          "name": [
            "Oncology Department and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maimon", 
        "givenName": "Ofra", 
        "id": "sg:person.01073162216.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073162216.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hadassah Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.17788.31", 
          "name": [
            "Nuclear Medicine Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krausz", 
        "givenName": "Yodphat", 
        "id": "sg:person.01041615547.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041615547.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hadassah Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.17788.31", 
          "name": [
            "Nuclear Medicine Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Godefroy", 
        "givenName": "Jeremy", 
        "id": "sg:person.013325501702.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013325501702.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Neuroendocrine Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia", 
            "Divison Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michael", 
        "givenName": "Michael", 
        "id": "sg:person.0673420201.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673420201.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hadassah Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.17788.31", 
          "name": [
            "Neuroendocrine Tumour Unit, Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gross", 
        "givenName": "David J.", 
        "id": "sg:person.01125011425.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125011425.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Melbourne", 
          "id": "https://www.grid.ac/institutes/grid.1008.9", 
          "name": [
            "Centre for Cancer Imaging, Peter MacCallum Cancer Centre, 305 Grattan Street, 3000, Melbourne, VIC, Australia", 
            "Neuroendocrine Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia", 
            "The Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hicks", 
        "givenName": "Rodney J.", 
        "id": "sg:person.01121233254.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121233254.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-016-3527-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007309336", 
          "https://doi.org/10.1007/s00259-016-3527-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-016-3527-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007309336", 
          "https://doi.org/10.1007/s00259-016-3527-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ecl.2010.12.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013174164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq192", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013184111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq192", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013184111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2788-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018243354", 
          "https://doi.org/10.1007/s00259-014-2788-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2788-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018243354", 
          "https://doi.org/10.1007/s00259-014-2788-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/erc-10-0152", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020394079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000355612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024820517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ans.12854", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024833972"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000000894", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025101175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000000894", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025101175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2008.10.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026558254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000443172", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027686166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-010-1631-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028002113", 
          "https://doi.org/10.1007/s00259-010-1631-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000443167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034875616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2016.08.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040512984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000335594", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041927730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000443166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051543924"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-010-1483-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052925405", 
          "https://doi.org/10.1007/s00259-010-1483-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-010-1483-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052925405", 
          "https://doi.org/10.1007/s00259-010-1483-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/cbr.2009.0644", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059242987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2012-0263", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068164506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2012-0263", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068164506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074564841", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000457956", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083759122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-017-1273-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084033719", 
          "https://doi.org/10.1007/s12020-017-1273-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-017-1273-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084033719", 
          "https://doi.org/10.1007/s12020-017-1273-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000475526", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084810086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaoncol.2017.0589", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085082670"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03", 
    "datePublishedReg": "2019-03-01", 
    "description": "PURPOSE: Rectal neuroendocrine neoplasia (NEN) is more common than other NEN origins, but is less commonly metastatic. However, when present, distant disease carries a particularly poor prognosis. Evidence guiding optimal treatment of such patients is lacking. We assessed PRRT outcomes in patients with somatostatin receptor (SSTR) positive metastatic rectal NEN from two referral centres.\nMETHODS: Patients treated with PRRT were retrospectively reviewed. Morphologic (RECIST 1.1), SSTR imaging responses and toxicity were assessed 3\u00a0months post-PRRT. Kaplan-Meier estimate was used to determine progression-free survival (PFS) and overall survival (OS) from start of PRRT.\nRESULTS: Twenty-seven consecutive patients (M\u2009=\u200920, age 31-81 years) were reviewed. The majority (70%) had ENETs grade 2 disease (19 patients), three had Grade 3, one Grade 1, and four not documented. Overall, 63% (10/16 patients with available FDG PET/CT) had FDG avid disease. Twenty-six patients were treated for disease progression. Most had 177Lu-DOTA-octreotate with median cumulative activity of 30\u00a0GBq, median four\u00a0cycles. 14 patients had radiosensitising chemotherapy (5FU or capecitabine). At 3\u00a0months post-PRRT, CT disease control rate (DCR) was 96%: partial response was observed in 70% (19/27) and stable disease in 26%. All but one had partial SSTR imaging response. The median PFS was 29\u00a0months. Ten patients died, with median overall survival 81\u00a0months with a median follow-up of 67\u00a0months. Seventeen patients had further treatments after initial PRRT (10 had further cycles of PRRT). Three patients had grade 3 lymphopenia, without significant renal toxicity, MDS or leukaemia.\nCONCLUSION: Our results indicate high efficacy and morphologic responses with minimal toxicity and very encouraging survival from PRRT in patients with metastatic rectal NEN despite the adverse prognostic features of this cohort. Further prospective PRRT trials are warranted in this subgroup.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00259-018-4196-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }
    ], 
    "name": "Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)", 
    "pagination": "1-10", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "382da55680b5837736ba4a64e775388a0edb032d22a426536126ba3cff00e335"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30343432"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101140988"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-018-4196-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107740065"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-018-4196-8", 
      "https://app.dimensions.ai/details/publication/pub.1107740065"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000567.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00259-018-4196-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4196-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4196-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4196-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4196-8'


 

This table displays all metadata directly associated to this object as RDF triples.

218 TRIPLES      21 PREDICATES      50 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-018-4196-8 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N2e4dfd00487d4f6495bad286f796f782
4 schema:citation sg:pub.10.1007/s00259-010-1483-4
5 sg:pub.10.1007/s00259-010-1631-x
6 sg:pub.10.1007/s00259-014-2788-5
7 sg:pub.10.1007/s00259-016-3527-x
8 sg:pub.10.1007/s12020-017-1273-x
9 https://app.dimensions.ai/details/publication/pub.1074564841
10 https://doi.org/10.1001/jamaoncol.2017.0589
11 https://doi.org/10.1016/j.ctrv.2016.08.006
12 https://doi.org/10.1016/j.ecl.2010.12.005
13 https://doi.org/10.1016/j.ejca.2008.10.026
14 https://doi.org/10.1089/cbr.2009.0644
15 https://doi.org/10.1093/annonc/mdq192
16 https://doi.org/10.1097/rlu.0000000000000894
17 https://doi.org/10.1111/ans.12854
18 https://doi.org/10.1159/000335594
19 https://doi.org/10.1159/000355612
20 https://doi.org/10.1159/000443166
21 https://doi.org/10.1159/000443167
22 https://doi.org/10.1159/000443172
23 https://doi.org/10.1159/000457956
24 https://doi.org/10.1159/000475526
25 https://doi.org/10.1634/theoncologist.2012-0263
26 https://doi.org/10.1677/erc-10-0152
27 schema:datePublished 2019-03
28 schema:datePublishedReg 2019-03-01
29 schema:description PURPOSE: Rectal neuroendocrine neoplasia (NEN) is more common than other NEN origins, but is less commonly metastatic. However, when present, distant disease carries a particularly poor prognosis. Evidence guiding optimal treatment of such patients is lacking. We assessed PRRT outcomes in patients with somatostatin receptor (SSTR) positive metastatic rectal NEN from two referral centres. METHODS: Patients treated with PRRT were retrospectively reviewed. Morphologic (RECIST 1.1), SSTR imaging responses and toxicity were assessed 3 months post-PRRT. Kaplan-Meier estimate was used to determine progression-free survival (PFS) and overall survival (OS) from start of PRRT. RESULTS: Twenty-seven consecutive patients (M = 20, age 31-81 years) were reviewed. The majority (70%) had ENETs grade 2 disease (19 patients), three had Grade 3, one Grade 1, and four not documented. Overall, 63% (10/16 patients with available FDG PET/CT) had FDG avid disease. Twenty-six patients were treated for disease progression. Most had 177Lu-DOTA-octreotate with median cumulative activity of 30 GBq, median four cycles. 14 patients had radiosensitising chemotherapy (5FU or capecitabine). At 3 months post-PRRT, CT disease control rate (DCR) was 96%: partial response was observed in 70% (19/27) and stable disease in 26%. All but one had partial SSTR imaging response. The median PFS was 29 months. Ten patients died, with median overall survival 81 months with a median follow-up of 67 months. Seventeen patients had further treatments after initial PRRT (10 had further cycles of PRRT). Three patients had grade 3 lymphopenia, without significant renal toxicity, MDS or leukaemia. CONCLUSION: Our results indicate high efficacy and morphologic responses with minimal toxicity and very encouraging survival from PRRT in patients with metastatic rectal NEN despite the adverse prognostic features of this cohort. Further prospective PRRT trials are warranted in this subgroup.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf sg:journal.1297401
34 schema:name Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
35 schema:pagination 1-10
36 schema:productId N1774e078a6134ede91d669b4430f0786
37 N30bd3ad3e771457c84c954cded2a5338
38 N8d981708c8724ae7a1cd40a1e5b0fc26
39 Ne297ccb197384cfea860a7c00d6b6135
40 Nffb0f632d45f4deb8fed30982f0121ca
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107740065
42 https://doi.org/10.1007/s00259-018-4196-8
43 schema:sdDatePublished 2019-04-10T15:10
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N8afdf107d5e74becb054c5f7a704db8c
46 schema:url https://link.springer.com/10.1007%2Fs00259-018-4196-8
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N04512d47a3ad40eb8ef06cfa8aeea696 rdf:first sg:person.01126121154.83
51 rdf:rest N2087752acdc149f89c1aa6a240f3aeb3
52 N1774e078a6134ede91d669b4430f0786 schema:name readcube_id
53 schema:value 382da55680b5837736ba4a64e775388a0edb032d22a426536126ba3cff00e335
54 rdf:type schema:PropertyValue
55 N2087752acdc149f89c1aa6a240f3aeb3 rdf:first sg:person.01012460764.55
56 rdf:rest Nb5f54ee7a4d94c3783a83aafe9a5f168
57 N2e4dfd00487d4f6495bad286f796f782 rdf:first sg:person.01122451566.24
58 rdf:rest N04512d47a3ad40eb8ef06cfa8aeea696
59 N30bd3ad3e771457c84c954cded2a5338 schema:name pubmed_id
60 schema:value 30343432
61 rdf:type schema:PropertyValue
62 N3d0ba6fae174438889e575404489e612 rdf:first sg:person.016475560707.20
63 rdf:rest Nbdecee6b35264bfeaa07a398a8b58679
64 N3fcc8139bf5e41e5b7646fb5140ab244 rdf:first sg:person.01121233254.97
65 rdf:rest rdf:nil
66 N685327a5edcb46ffbe88d5ec3f6d36f2 rdf:first sg:person.013325501702.36
67 rdf:rest Ncffde36c62a64b10b2af445b9926497e
68 N8afdf107d5e74becb054c5f7a704db8c schema:name Springer Nature - SN SciGraph project
69 rdf:type schema:Organization
70 N8d981708c8724ae7a1cd40a1e5b0fc26 schema:name doi
71 schema:value 10.1007/s00259-018-4196-8
72 rdf:type schema:PropertyValue
73 Na0cd4391c07949e5ac1f5b69952d70e2 rdf:first sg:person.01125011425.03
74 rdf:rest N3fcc8139bf5e41e5b7646fb5140ab244
75 Nb5f54ee7a4d94c3783a83aafe9a5f168 rdf:first sg:person.014667211005.35
76 rdf:rest N3d0ba6fae174438889e575404489e612
77 Nbdecee6b35264bfeaa07a398a8b58679 rdf:first sg:person.01073162216.43
78 rdf:rest Nd13b11950abf48588ad0b8c3b8b8622c
79 Ncffde36c62a64b10b2af445b9926497e rdf:first sg:person.0673420201.89
80 rdf:rest Na0cd4391c07949e5ac1f5b69952d70e2
81 Nd13b11950abf48588ad0b8c3b8b8622c rdf:first sg:person.01041615547.78
82 rdf:rest N685327a5edcb46ffbe88d5ec3f6d36f2
83 Ne297ccb197384cfea860a7c00d6b6135 schema:name nlm_unique_id
84 schema:value 101140988
85 rdf:type schema:PropertyValue
86 Nffb0f632d45f4deb8fed30982f0121ca schema:name dimensions_id
87 schema:value pub.1107740065
88 rdf:type schema:PropertyValue
89 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
90 schema:name Medical and Health Sciences
91 rdf:type schema:DefinedTerm
92 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
93 schema:name Oncology and Carcinogenesis
94 rdf:type schema:DefinedTerm
95 sg:journal.1297401 schema:issn 1619-7070
96 1619-7089
97 schema:name European Journal of Nuclear Medicine and Molecular Imaging
98 rdf:type schema:Periodical
99 sg:person.01012460764.55 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
100 schema:familyName Hofman
101 schema:givenName Michael S.
102 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012460764.55
103 rdf:type schema:Person
104 sg:person.01041615547.78 schema:affiliation https://www.grid.ac/institutes/grid.17788.31
105 schema:familyName Krausz
106 schema:givenName Yodphat
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041615547.78
108 rdf:type schema:Person
109 sg:person.01073162216.43 schema:affiliation https://www.grid.ac/institutes/grid.17788.31
110 schema:familyName Maimon
111 schema:givenName Ofra
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073162216.43
113 rdf:type schema:Person
114 sg:person.01121233254.97 schema:affiliation https://www.grid.ac/institutes/grid.1008.9
115 schema:familyName Hicks
116 schema:givenName Rodney J.
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121233254.97
118 rdf:type schema:Person
119 sg:person.01122451566.24 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
120 schema:familyName Kong
121 schema:givenName Grace
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122451566.24
123 rdf:type schema:Person
124 sg:person.01125011425.03 schema:affiliation https://www.grid.ac/institutes/grid.17788.31
125 schema:familyName Gross
126 schema:givenName David J.
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125011425.03
128 rdf:type schema:Person
129 sg:person.01126121154.83 schema:affiliation https://www.grid.ac/institutes/grid.17788.31
130 schema:familyName Grozinsky-Glasberg
131 schema:givenName Simona
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126121154.83
133 rdf:type schema:Person
134 sg:person.013325501702.36 schema:affiliation https://www.grid.ac/institutes/grid.17788.31
135 schema:familyName Godefroy
136 schema:givenName Jeremy
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013325501702.36
138 rdf:type schema:Person
139 sg:person.014667211005.35 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
140 schema:familyName Akhurst
141 schema:givenName Tim
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014667211005.35
143 rdf:type schema:Person
144 sg:person.016475560707.20 schema:affiliation https://www.grid.ac/institutes/grid.17788.31
145 schema:familyName Meirovitz
146 schema:givenName Amichay
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016475560707.20
148 rdf:type schema:Person
149 sg:person.0673420201.89 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
150 schema:familyName Michael
151 schema:givenName Michael
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673420201.89
153 rdf:type schema:Person
154 sg:pub.10.1007/s00259-010-1483-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052925405
155 https://doi.org/10.1007/s00259-010-1483-4
156 rdf:type schema:CreativeWork
157 sg:pub.10.1007/s00259-010-1631-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028002113
158 https://doi.org/10.1007/s00259-010-1631-x
159 rdf:type schema:CreativeWork
160 sg:pub.10.1007/s00259-014-2788-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018243354
161 https://doi.org/10.1007/s00259-014-2788-5
162 rdf:type schema:CreativeWork
163 sg:pub.10.1007/s00259-016-3527-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007309336
164 https://doi.org/10.1007/s00259-016-3527-x
165 rdf:type schema:CreativeWork
166 sg:pub.10.1007/s12020-017-1273-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1084033719
167 https://doi.org/10.1007/s12020-017-1273-x
168 rdf:type schema:CreativeWork
169 https://app.dimensions.ai/details/publication/pub.1074564841 schema:CreativeWork
170 https://doi.org/10.1001/jamaoncol.2017.0589 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085082670
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/j.ctrv.2016.08.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040512984
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/j.ecl.2010.12.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013174164
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/j.ejca.2008.10.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026558254
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1089/cbr.2009.0644 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059242987
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1093/annonc/mdq192 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013184111
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1097/rlu.0000000000000894 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025101175
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1111/ans.12854 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024833972
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1159/000335594 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041927730
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1159/000355612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024820517
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1159/000443166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051543924
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1159/000443167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034875616
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1159/000443172 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027686166
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1159/000457956 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083759122
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1159/000475526 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084810086
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1634/theoncologist.2012-0263 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068164506
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1677/erc-10-0152 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020394079
203 rdf:type schema:CreativeWork
204 https://www.grid.ac/institutes/grid.1008.9 schema:alternateName University of Melbourne
205 schema:name Centre for Cancer Imaging, Peter MacCallum Cancer Centre, 305 Grattan Street, 3000, Melbourne, VIC, Australia
206 Neuroendocrine Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
207 The Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, VIC, Australia
208 rdf:type schema:Organization
209 https://www.grid.ac/institutes/grid.1055.1 schema:alternateName Peter MacCallum Cancer Centre
210 schema:name Centre for Cancer Imaging, Peter MacCallum Cancer Centre, 305 Grattan Street, 3000, Melbourne, VIC, Australia
211 Divison Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
212 Neuroendocrine Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
213 rdf:type schema:Organization
214 https://www.grid.ac/institutes/grid.17788.31 schema:alternateName Hadassah Medical Center
215 schema:name Neuroendocrine Tumour Unit, Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
216 Nuclear Medicine Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
217 Oncology Department and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
218 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...